Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 57, 1999, Pages 116-123

  Bachert, C ^a   Geveart, P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 5;

ALLERGIC RHINITIS; CELL ACTIVATION; CYTOKINE RELEASE; EOSINOPHILIA; HUMAN; INFLAMMATORY CELL; INTRANASAL DRUG ADMINISTRATION; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, INTRANASAL; CELL ADHESION MOLECULES; CYTOKINES; EOSINOPHILS; GLUCOCORTICOIDS; HUMANS; INFLAMMATION MEDIATORS; NASAL POLYPS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032696750     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. 1. Bousquet J, Vignola AM, Campbell AM, Michel F. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996;110:207-218.
2. 2. Bachert C, Prohaska P, Pipkorn U. IgE positive mast cells on the human nasal mucosal surface in response to allergen exposure. Rhinology 1990;28:149-158.
3. 3. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effects of systemic steroid pretreatment. Am Rev Respir Dis 1988;138:406-412.
4. 4. Fokkens WJ, Broekhuis-Fluitsma DM, Rijntjes E, Vroom TM, Hoefsmit EC. Langerhans cells in nasal mucosa of patients with grass pollen allergy. Immunobiology 1991;182:135-142.
5. 5. Calderon MA, Lozewicz S, Prior A, et al. Lymphocyte infiltration and thickness of the nasal mucus membrane in perennial and seasonal allergic rhinitis. J Allergy Clin Immunol 1994;93:635-643.
6. 6. Montefort S, Feather IH, Wilson SJ, et al. The expression of leucocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992;7:393-398.
7. 7. Howarth PH. The cellular basis for allergic rhinitis. Eur J Allergy Clin Immunol 1995;50:6-10.
8. 8. Bachert C, Wagenmann M, Holtappels G. Cytokines and adhesion molecules in allergic rhinitis. Am J Rhinol 1998;12:3-8.
9. 9. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
10. 10. Kuna P, Reddigari SR, Rucinski D, Kaplan AP. Further charaterization of histamine releasing chemokines present in fractioned supematants derived from human mononuclear cells. Clin Exp Allergy 1996;26:926-933.
11. 11. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993;150:1932-1943.
12. 12. Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CGA. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-710.
13. 13. Wang D, Clement P, Smitz J, De Wacle M, Derde M. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int. Arch Allergy Immunol 1995;106:278-285.
14. 14. Gosset P, Malaquin F, Delneste Y, et al. IL-6 and IL-1 production is associated with antigen-induced late nasal response. J Allergy Clin Immunol 1993;92:878-890.
15. 15. Bachert C, Hauser U, Prem B, et al. Proinflammatroy cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1995;252:S44-S4916.
16. 16. Durham SR, Ying S, Varney VA, et al. Cytokine mRNA expression of IL-3, IL-4, IL-5, and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
17. 17. Baroody FM, Lee BJ, Lim MC, Bochner BS, et al. Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol 1995;252:S50-S58.
18. 18. van de Stolpe A, Caldenhoven E, Raaijmakers JAM, et al. Glucocorticoid-mediated repression of Intercellular Adhesion Molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 1993;8:340-347.
19. 19. Ciprandi G, Pronzato C, Ricca V, et al. Allergen specific challenge induces Intercellular Adhesion Molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994;150:1653-1659.
20. 20. Altman LC, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate Intercellular Adhesion Molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993;92:527-536.
21. 21. Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Inr Arch Allergy Appl Immunol 1999;118:375-379.
22. 22. Bachert C, Wagenmann M, Rudack C, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Eur J Allergy Clin Immunol 1998;53:2-13.
23. 23. Bachert C, Tavernier J, Rudack C, Van Cauwenberge P. IL-5 receptor regulation in allergic rhintis and nasal polyposis. J Allergy Clin Immunol 1998;101:250-251.
24. 24. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842.
25. 25. Simon HU. Novel therapeutic strategies via the apoptosis pathways to resolve chronic cosinophilic inflammation. Cell Death Diff 1996;3:349-356.
26. 26. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-3908.
27. 27. Stellato C, Beck LA, Gorgone GA, et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol 1995;155:410-3908.
28. 28. Beck LA, Schall TJ, Beall LD, et al. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps. J Allergy Clin Immunol 1994;93:A234.
29. 29. Swiebert LA, Beck LA, Stellato C, et al. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol 1996;97:143-152.
30. 30. Pedersen S, O'Byrne P. A Comparison of the efficacy and safety of inhaled corticosteroids in asthma. Eur J Allergy Clin Immunol 1997;52(S39):1-34.
31. 31. Barnes PJ, Adock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-441.
32. 32. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-286.
33. 33. Auphan N, DiDonato JA, Rossette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NK-κB activity through inducion of IκB synthesis. Science 1995;270:286.
34. 34. Meltzer EO. Nasal cytological changes following pharmacological intervention. Eur J Allergy e Clin Immunol 1995;50:15-20.
35. 35. Fokkens WJ, Godthelp T, Holm AF, Blom H, Klein-Jan A. Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy. Eur J Allergy Clin Immunol 1997;52(Suppl, 36):26-32.
36. 36. Rak S, Jacobson MR, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-939.
37. 37. Baroody FM, Rouadi P, Driscoll PV, Bochner BS, Naclerio RM. Intranasal beclomethasone reduces allergen-induced symptoms and supperficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med 1998;157:899-906.
38. 38. Mygind N, Lund V. Topical corticosteroid therapy of rhinitis. Clin Immunother 1996;5:122-136.
39. 39. Brattsand R, Selroos O. Current drugs for respiratory diseases. In: Page CP, Metzger WJ, editors. Advances in clinical pharmacology: drugs and the lung. New York: Raven Press, 1994:101-220.
40. 40. Wang JH, Davalia JI, Xia C, et al. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Biol 1996;14:27-35.
41. 41. Weido AJ, Reece LM, Alam R, et al. Intranasal fluticasone proprionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996;77:407-415.
42. 42. Roca-Ferrer J, Mullol J, Lopez E, et al. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophile survival and GM-CSF secretion. Eur Respir J 1997;10:1489-1495.
43. 43. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial leucocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992;89:9991-9995.
44. 44. Hilberg O. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Eur J Allergy Clin Immunol 1995;50:683-688.
45. 45. Bunnag C, Jareoncharsri P, Wong ECK. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Eur J Allergy Clin Immunol 1992;47:313-317.
46. 46. Storms WW. Treatment of seasonal allergic rhinitis with fluticasone propionate aqucous nasal spray: review of comparator studies. Eur J Allergy Clin Immunol 1995;50(Suppl. 23):25-29.
47. 47. Tarlo SM, Cockroft DW, Dolovich J, et al. Beclomethasone diproprionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977;59:232-236.